MERILOG
LIVE

Serial Number

99084375

Owner

Sanofi

Attorney

Alexandra Kochian

Filing Date

Mar 14, 2025

Add to watchlist:

No watchlists yet
View on USPTO

MERILOG Trademark

Serial Number: 99084375

MERILOG is a trademark filed by Sanofi on March 14, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Sanofi (13 trademarks)

Paris 75017 , FR

Entity Type: 03

Trademark Details

Filing Date

March 14, 2025

Registration Date

Not Registered

Published for Opposition

December 30, 2025

Goods & Services

Providing medical information in the field of diabetes; providing medical information; Medical services; medical services in the field of diabetes, autoimmune diseases and disorders, and related diseases and disorders, namely, providing medical and psychological support for healthcare professionals, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases and disorders; providing medical information in the field of prevention and treatment of diabetes, autoimmune diseases and disorders, and diseases and disorders related to diabetes; providing medical information in the field of diabetes, treatment of the disease, burden of the disease, and pathophysiology of the autoimmune nature of the disease via a website; providing medical information in the field of diabetes, autoimmune diseases, and related diseases and disorders, and on the prevention and early diagnosis of asymptomatic Type 1 diabetes, to health care providers; providing medical information in the field of diabetes and autoimmune diseases to patients, health care professionals, and caregivers, all of the foregoing distributed via various platforms across multiple forms of transmission media, namely, via electronic media, the Internet, and social network platform; providing educational information to caregivers and patients in the field of personal support services for families of patients with life threatening disorders, namely, information concerning companionship support, help with medical forms, patient treatment management, all of the aforesaid provided by means of website or telephone, non-downloadable webinars, and printed materials distributed in connection therewith; Providing educational information about healthcare

Pharmaceutical preparations for human use for the prevention and treatment of diabetes; insulin

Providing training in the field of diabetes and diabetes care provided by means of injecting insulin; publication of printed and online articles and scientific journals in the field of health care and medicine; Educational services, namely, developing, arranging, and conducting educational conferences and programs and providing courses of instruction in the field of healthcare and medicine for health care providers, care givers, health care insurers, payers in the healthcare field, patients with diabetes and related diseases and disorders, and patients with autoimmune diseases; Entertainment services, namely, providing podcasts in the field of healthcare and medicine; Educational services, namely, conducting conferences, training, seminars, congresses, presentations, and workshops in the field of healthcare and medicine and distribution of educational materials in connection therewith, all the foregoing distributed via various platforms across multiple forms of transmission media, namely, via the Internet and social network platforms

Administration of a program for enabling participants to obtain discounts on products and services; administration of a discount program for enabling participants to obtain discounts on goods and services through use of a discount membership card; promoting public awareness of medications and treatments for diabetes; Providing business information in the field of patient relationship management services for the purpose of assisting prospective patients regarding the treatment of disease via a web site; Providing business information in the field of business administration of patient reimbursement programs, namely, medical treatment payment plan options for patients undergoing treatment of disease

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 24, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Dec 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 1, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 31, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 31, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 31, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 22, 2025 GNRN
NON-FINAL ACTION E-MAILED
Aug 22, 2025 GNRT
NON-FINAL ACTION WRITTEN
Aug 22, 2025 CNRT
ASSIGNED TO EXAMINER
Aug 14, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 3, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 3, 2025 NWOS
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 30, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 30, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 30, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 30, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 30, 2025 REAP
APPLICATION FILING RECEIPT MAILED
Mar 14, 2025 MAFR
NEW APPLICATION ENTERED
Mar 14, 2025 NWAP